Filing Details
- Accession Number:
- 0001127602-19-026527
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-13 16:03:29
- Reporting Period:
- 2019-08-09
- Accepted Time:
- 2019-08-13 16:03:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Bausch Health Companies Inc. | BHC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1681871 | Christina Ackermann | 400 Somerset Corporate Boulevard Bridgewater NJ 08807 | Evp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Disposition | 2019-08-09 | 7,779 | $22.39 | 53,943 | No | 4 | F | Direct | |
Common Stock, No Par Value | Disposition | 2019-08-12 | 3,418 | $22.45 | 50,525 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price in Column 4 reflects the average weighted sale price for the transactions aggregated on this Form 4. The sales price per share reported on this Form 4 range from $22.30 to $22.61.The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares sold at each separate price.